| 000 | 01394 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513112458.0 | ||
| 264 | 0 | _c19970327 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, G | |
| 245 | 0 | 0 |
_aDifferential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a3499-505 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAnthraquinones _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 |
_aAporphines _xmetabolism |
| 650 | 0 | 4 | _aBenzylisoquinolines |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aDoxorubicin _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEtoposide _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoquinolines _xmetabolism |
| 650 | 0 | 4 |
_aPaclitaxel _xmetabolism |
| 650 | 0 | 4 |
_aPyrazoles _xmetabolism |
| 650 | 0 | 4 | _aPyrazolones |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 700 | 1 | _aTeicher, B A | |
| 700 | 1 | _aFrei, E | |
| 773 | 0 |
_tAnticancer research _gvol. 16 _gno. 6B _gp. 3499-505 |
|
| 999 |
_c9030811 _d9030811 |
||